Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Tumor Immune Regulation by Natural Products: Mechanistic Insights and Therapeutic Potential.

Created on 10 Jul 2026

Authors

Qianqian Wang, Zihan Zhang, Xiaotong Sun, Zihan Zhang, Qiwen Lu, Shan Deng, Xuan Han

Published in

The American journal of Chinese medicine. Pages 1-35. Jul 10, 2026. Epub Jul 10, 2026.

Abstract

Frequently evolving into a highly immunosuppressive niche that facilitates tumor growth and metastasis, the tumor microenvironment (TME) serves as the primary site for interactions between tumor cells and the host immune system. Reversing this immunosuppressive state therefore represents a pivotal strategy for antitumor therapy. Natural products possess the distinct advantages of multi-targeted and multi-pathway mechanisms, as well as the capacity to enhance therapeutic efficacy while attenuating systemic toxicity. These characteristics perfectly align with the core principles of antitumor immunotherapy. Accumulating evidence demonstrates that natural products including Ganoderma lucidum polysaccharides, Astragalus polysaccharides, and Lycium barbarum polysaccharides, as well as bioactive single compounds such as curcumin, resveratrol, and bufalin, exert potent antitumor immunotherapeutic effects by remodeling the suppressive TME. Consequently, they are increasingly being utilized as synergists or adjuvants in advanced therapeutic modalities, which include adoptive immune cell therapy, cancer vaccines, and immune checkpoint inhibitors. In addition, the discovery of novel potential regulatory factors for tumor immunotherapy from natural products has attracted significant attention. This review provides a comprehensive overview of the latest progress on how natural products reshape the immunosuppressive landscape and enhance the systemic antitumor response. Ultimately, this review both underscores the immense translational potential of natural products in tumor immunotherapy and highlights critical directions for future standardized research.

PMID:
42425905
Bibliographic data and abstract were imported from PubMed on 10 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement